Elastin Degradation: An Effective Biomarker in COPD

References

• Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence and future trends. Lancet 2007; 370:765–773.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. AJRCCM 2007; 176:532–555.
   Web of Science ®Google Scholar
• Minino, AM, Xu, J, Kochanek, MA. Deaths: Preliminary Data for 2008. National Vital Statistics Reports 2010; 59:1–32.
   Google Scholar
• http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentTools QualificationProgram/ucm284076.htm.
   Google Scholar
• DeGruttola VG, Clax P, DeMets DL, Downing GJ, Ellenbert SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Contr Clin Trials 2001; 22:485–502.
   PubMedGoogle Scholar
• Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users’ guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points: evidence-based medicine working group. JAMA 1999; 282:771–778.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry chronic obstructive pulmonary disease: Developing drugs for treatment. 2007 [accessed April 14, 2009]. Available from: http://www.fda.gov/CDER/GUIDANCE/7875dft.pdf.
   Google Scholar
• Mecham RP. Elastin fibers in the lung. In Crystal RG, West JB, Weibel ER, Barnes PJ eds: Scientific Foundations 1997, Philadelphia, Lippincott-Raven, 729–736.
   Google Scholar
• Sandberg LB, Soskel NT, Leslie JG. Elastin structure, biosynthesis, and relation to disease states. NEJM 1981; 304(10):566–579.
   PubMed Web of Science ®Google Scholar
• Kuhn C III, Oldmixon EH. The interstitium of the lung. In: Schraufnagel DE, ed. Electron Microscopy of the Lung. New York: Marcel Dekker, 1990: 177–214.
   Google Scholar
• Wright RR. Elastic tissue of normal and emphysematous lungs – a tridimensional histologic study. Am J Path 1961; 39:355–367.
   PubMed Web of Science ®Google Scholar
• Ma S, Lieberman S, Turino GM, Lin YY. The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum: Proc Natl Acad Sci USA 2003; 100:12941–12943.
   PubMed Web of Science ®Google Scholar
• Laurell C-B, Eriksson S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132–140.
   Web of Science ®Google Scholar
• Brantly MS, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138:327–336.
   PubMed Web of Science ®Google Scholar
• Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Internat J COPD 2008; 3(2):253–268.
   Google Scholar
• Abboud RT, Fera T, Richter A, Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. ARRD 1985; 131:79–85.
   PubMed Web of Science ®Google Scholar
• Darnule TV, McKee M, Darnule AT, Turino GM, Mandl I. Solid-phase radioimmunoassay for estimation of elastin peptides in human sera. Anal Biochem 1982; 122:302–307.
   PubMed Web of Science ®Google Scholar
• Goldstein RA, Starcher BC. Urinary excretion of elastin peptides containing desmosine after intratracheal injection of elastin in hamsters. J Clin Invest 1978; 61:1286–1290.
   PubMed Web of Science ®Google Scholar
• Luisetti M, Ma S, Iadarola P, Stone PJ, Viglio S, Casado B, Lin YY, Snider GL, Turino GM. Desmosine as a biomarker of elastin degradation in COPD: Current status and future directions. ERJ 2008; 32(5):1146–1157.
   PubMed Web of Science ®Google Scholar
• Starcher BC. Antibodies to elastin. Meth Enzymol 1982; 82:759–762.
   PubMed Web of Science ®Google Scholar
• Kucich U, Christner P, Lippmann M, Utilization of a peroxidase antiperoxidase complex in an enzyme-linker immunosorbent assay of elastin-derived peptides in human plasma. Am Rev Respir Dis 1985; 131:709–713.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Ishimori K, Verplanke AJ, Matsuki H, Kasuga H. An enzyme-linked immunosorbena assay (ELISA) for the quantitation of urinary desmosine. Tokai J Exp Clin Med 1989; 14:347–356.
   PubMedGoogle Scholar
• Stone PJ, Bryan-Rhafdi H, Lucey EC, Measurement of urinary desmosine by isotope dilution and high performance liquid chromatography. Correlation between elastase-induced air-sace enlargement in the hamster and elevation of urinary desmosine. Am Rev Respir Dis 1991; 144:284–290.
   PubMed Web of Science ®Google Scholar
• Harel S, Janoff A, Yu SY, Hurewitz A, Bergofsky Eh. Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am Rev Respir Dis 1980; 122:769–773.
   PubMed Web of Science ®Google Scholar
• Stone PJ, Gottlieb DJ, O’Connor GT, Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:952–959.
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Stone PJ, Sparrow D, Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. AJRCCM 1996; 154:1290–1295.
   Web of Science ®Google Scholar
• Viglio S, Iadarola P, Lupi A, MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J 2000; 15:1039–1045.
   PubMed Web of Science ®Google Scholar
• Ma S, Lin YY, Turino GM. Measurement of desmosine and isodesmosine by mass spectrometry in COPD. Chest 2007, 131:1363–1371.
   PubMed Web of Science ®Google Scholar
• Rodriguez JR, Seals JE, Radin A, Lin JS, MandlI, Turino GM. Neutrophil lysosomal elastase activity in normal subjects and in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119:409–417.
   PubMed Web of Science ®Google Scholar
• Ma S, Turino GM, Lin YY. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LLC-MS/MS as biomarkers for elastin degradation. J Chromatogr B 2011; 879:1893–1898.
   PubMed Web of Science ®Google Scholar
• Albarbarawi O, Barton A, Lin Z, Measurement of urinary total desmosine and isodesnosine using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 2010; 82(9):2745–2750.
   Web of Science ®Google Scholar
• Ma S, Lin YY, Turino GM. The effect of Tiotropium (TIO) on levels of desmosine and isodesmosine (D/I) in urine, plasma and sputum in COPD. Respir-Res 2009; 12:10.
   Google Scholar
• Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker RG, Gosens R, Maaringh H, Zaagsma J, Meurs H. Tiotropium inhibits pulmonary inflammation and remodeling in a guinea pig model of COPD. EUR Respir J 2011; Feb 24, 2011 (Epub ahead of print, US National Library of Medicine, NIH, PubMed).
   PubMed Web of Science ®Google Scholar
• Cantor JO, Cerreta JM, Ochoa M, Ma S, Liu M, Turino GM. Therapeutic effects of hyaluronan on smoke-induced elastic fiber injury: Does delayed treatment affect efficacy? Lung 2011; 189:51–56.
   PubMed Web of Science ®Google Scholar
• Fregonese L, Ferrari F, Funagalli M, Luisetti M, Stolk J, Iadarola P. Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antitrypsin deficiency-related COPD. J COPD 2011; 3:229–333.
   Google Scholar
• Lindberg CA, Engstrom G, Gerhardsson de Verdier M, Nihlen U, Anderson M, Forsman-Semb K, Svartengren M. Total desmosine in plasma and urine correlate with lung function. ERJ 2012; 29:839–845.
   Web of Science ®Google Scholar